Ken Griffin started to build up the position in Impel Pharmaceuticals in Q3 2022 and continued to invest until Q4 2022. Since then they sold 49.8k shares. The investor sold all their shares in Q1 2023 and doesn't own any shares in Impel Pharmaceuticals anymore.